Rep. Rick Larsen Sells Sonida Senior Living, Inc. (NYSE:SNDA) Shares

Representative Rick Larsen (Democratic-Washington) recently sold shares of Sonida Senior Living, Inc. (NYSE:SNDA). In a filing disclosed on April 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Sonida Senior Living stock on April 7th. The trade occurred in the Representative’s “AMERIPRISE ONE ACCOUNT” account.

Representative Rick Larsen also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Broadridge Financial Solutions (NYSE:BR) on 4/7/2026.
• Sold $1,001 – $15,000 in shares of American Water Works (NYSE:AWK) on 4/7/2026.
• Sold $1,001 – $15,000 in shares of Paychex (NASDAQ:PAYX) on 4/7/2026.
• Purchased $1,001 – $15,000 in shares of NextEra Energy (NYSE:NEE) on 4/7/2026.
• Sold $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 4/7/2026.
• Purchased $1,001 – $15,000 in shares of Wabtec (NYSE:WAB) on 4/7/2026.
• Purchased $1,001 – $15,000 in shares of Carrier Global (NYSE:CARR) on 4/7/2026.
• Purchased $1,001 – $15,000 in shares of Casey’s General Stores (NASDAQ:CASY) on 4/7/2026.

Sonida Senior Living Trading Up 0.9%

SNDA opened at $35.33 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 136.33. Sonida Senior Living, Inc. has a fifty-two week low of $20.30 and a fifty-two week high of $37.57. The stock has a market cap of $1.67 billion, a P/E ratio of -8.39 and a beta of 0.75.

Analysts Set New Price Targets

Several research firms have recently commented on SNDA. Royal Bank Of Canada initiated coverage on Sonida Senior Living in a report on Friday, March 27th. They set an “outperform” rating and a $39.00 target price for the company. Morgan Stanley raised their price target on Sonida Senior Living from $28.00 to $31.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 7th. Weiss Ratings began coverage on Sonida Senior Living in a research report on Wednesday, March 25th. They set a “sell (d+)” rating for the company. Finally, Cantor Fitzgerald initiated coverage on Sonida Senior Living in a research report on Monday. They issued an “overweight” rating and a $36.00 target price on the stock. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $35.33.

About Representative Larsen

Rick Larsen (Democratic Party) is a member of the U.S. House, representing Washington’s 2nd Congressional District. He assumed office on January 3, 2001. His current term ends on January 3, 2027.

Larsen (Democratic Party) is running for re-election to the U.S. House to represent Washington’s 2nd Congressional District. He declared candidacy for the 2026 election.

Since at least 2011, Larsen has been assigned to the Committee on Armed Services and the Committee on Transportation and Infrastructure.

Larsen’s first position as an elected official was in 1998 as a member of the Snohomish County Council.

Larsen earned his bachelor’s degree from Pacific Lutheran University. After earning his master’s degree in public affairs from the University of Minnesota, Larsen worked as the director of public affairs for the Washington State Dental Association and then as an economic development official with the Port of Everett. He went on to serve on the Snohomish County Council before seeking election to the U.S. House.

Sonida Senior Living Company Profile

Sonida Senior Living (NYSE: SNDA) is a publicly traded company that owns and operates senior living communities in the United States. The company’s core business centers on providing housing and care services for older adults, with an emphasis on assisted living, memory care and related supportive services tailored to residents’ needs.

Sonida’s communities combine residential accommodations with on-site services such as personal care assistance, medication management, dining programs, social and recreational activities, and clinical oversight.